GUGGENHIME ANDREW sold PCVX
July 6, 2026 · Form 4 insider transaction
GUGGENHIME ANDREW sold 7,913 shares of Vaxcyte, Inc. at $57.16 per share, a transaction worth $452.3K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
7,913
Price
$57.16
Total value
$452.3K
InsiderGUGGENHIME ANDREW
Role—
CompanyVaxcyte, Inc. (PCVX)
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJuly 6, 2026
Filing dateJuly 6, 2026
Shares owned after106,482
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted March 4, 2026.; The price reported is a weighted-average price. The shares were sold at prices ranging from $56.595 to $57.59. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.